Home healthcare company Amedisys said Monday that it has agreed to acquire UnitedHealth Group’s Optum in an all-cash transaction for $101 a share.
The bid was above Optum’s original offer in early June of $100 a share, or $3.3 billion, for the Baton Rouge, Louisiana-based company.
Home infusion company Option Care Health, which in early May announced plans to buy Amidisys for $3.6 billion in stock, said in a press release that it had terminated its merger agreement with company and will receive a termination fee of $106 million.
Transactions must be approved by shareholders and regulators.
This is an evolving story. Check back for updates.
